MBAI.c Up 360% in 6 Months Amidst the unfolding AI revolution, astute investors are tasked with the challenge of identifying intelligent solutions within the open market. A recent entrant arousing interest is MedBright AI Investments (Ticker: MBAI.c or MBAIF for US investors), positioned as a pioneering force in innovative AI-driven healthcare solutions. Overall this junior tech company is up 360% over the past 6 months.
At the forefront of technology, MedBright AI operates through its cutting-edge platform, "Medmatrix," harnessing the potential of AI and leveraging historical data encompassing medical, credit card, and driving records.
This fusion of data empowers the platform to predict optimal appointment durations for clinic patients, resulting in the creation of a more precise and efficient schedule for doctors, ultimately enhancing the overall patient experience. This solution addresses a significant healthcare challenge, particularly the inherent inefficiencies in doctor's waiting rooms, marking it as a noteworthy venture.
The potential impact of MedBright AI Investments transcends immediate gains. In the expansive $2.2 trillion healthcare market, the "Medmatrix" platform is poised to enhance efficiency by 10%, representing a substantial $220 billion opportunity.
The introduction of this solution aligns with a pivotal moment in AI capabilities, now capable of processing vast datasets to simulate and make accurate predictions, achieving what was previously deemed unattainable.
Investor Deck: https://assets-global.website-files.com/654400b037e09f716a28c32b/655f911132d0b133ffc9ca1c_Medbright%20Q4%202023%20Investor%20Presentation.pdf
Posted on behalf of MedBright AI Investments Inc.